Nektar Therapeutics | NKTR - Ordinary Share Capital

Nektar Therapeutics reported $19K in Ordinary Share Capital for its fourth fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Ordinary Share Capital Change
Agios Pharmaceuticals AGIO:US USD 71K 0
Astrazeneca AZN:US USD 387M 0
Baxter International BAX:US USD 683M 0
Biogen BIIB:US USD 100K 0
Bluebird Bio BLUE:US USD 829K 94K
Cara Therapeutics CARA:US USD 53K 0
Eisai 4523:JP JPY 44.99B 0
Esperion Therapeutics ESPR:US USD 75K 3K
Exelixis EXEL:US USD 324K 1000
GlaxoSmithKline GSK:LN GBP 1.35B 0
Halozyme Therapeutics HALO:US USD 135K 0
Immunogen IMGN:US USD 2.26M 52K
IONIS PHARMACEUT IONS:US USD 142K 0
Ironwood Pharmaceuticals IRWD:US USD 154K 1000
Macrogenics MGNX:US USD 617K 2K
Mirati Therapeutics MRTX:US USD 58K 0
Nektar Therapeutics NKTR:US USD 19K 0
Neurocrine Biosciences NBIX:US USD 100K 0
Novartis NOVN:VX USD 890M 0
Roche Holding ROG:VX 107M 0
Sarepta Therapeutics SRPT:US USD 9K 0
Seattle Genetics SGEN:US USD 187K 2K
Takeda 4502:JP JPY 1.68T 4M
Teva Pharmaceutical TEVA:IT USD 57M 0
Xencor XNCR:US USD 601K 3K
YTE INCY:US USD 223K 1000